While rare, propylthiouracil can trigger a rare immune condition that affects multiple body systems — including joints, skin, and the gut — not just the kidneys or lungs as often seen in other forms of vasculitis.
Claim Context
Propylthiouracil-induced ANCA-positive vasculitis is a rare adverse effect, with clinical presentations varying widely and including musculoskeletal, cutaneous, and gastrointestinal symptoms beyond the more commonly reported renal or pulmonary involvement.
“Patients have various presentations and symptoms such as (arthritis, edema)... Our case did not have changes in the liver function test, complete blood cell count, and renal function test... She also did not have any complaints of respiratory symptoms. Her manifestations were generalized arthritis and bone pain, abdominal pain, diarrhea, edema in both feet, alopecia areata, and livedo reticularis.”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
The full spectrum and relative frequency of clinical manifestations in propylthiouracil-induced ANCA-positive vasculitis across all reported cases.
A systematic review and meta-analysis of all published case reports and series (n≥100) describing PTU-induced ANCA vasculitis, extracting and categorizing all symptoms (musculoskeletal, cutaneous, GI, renal, pulmonary, neurological) and their frequencies, with standardized diagnostic criteria.
The incidence and pattern of multi-system symptoms in Graves' disease patients treated with propylthiouracil over time.
A prospective cohort study of 2,000 Graves' disease patients on PTU, with monthly symptom screening across 10 organ systems and quarterly ANCA testing over 3 years, to map the emergence and frequency of non-renal manifestations.
That propylthiouracil-induced vasculitis can present with gastrointestinal, cutaneous, and musculoskeletal symptoms in the absence of renal or pulmonary involvement.
A case series of 10 patients with PTU-induced ANCA vasculitis who lack renal or pulmonary symptoms but have arthritis, livedo reticularis, and abdominal pain, with confirmed ANCA positivity and resolution after PTU discontinuation.